Entia Biosciences Stock Price on August 7, 2023
ERGO Stock | USD 0.0002 0.00 0.00% |
If you're considering investing in Entia Pink Sheet, it is important to understand the factors that can impact its price. As of today, the current price of Entia Biosciences stands at 0.0002, as last reported on the 10th of January, with the highest price reaching 0.0002 and the lowest price hitting 0.0002 during the day. We have found three technical indicators for Entia Biosciences, which you can use to evaluate the volatility of the firm.
Entia Pink Sheet price history is provided at the adjusted basis, taking into account all of the recent filings.
Entia |
Sharpe Ratio = 0.0
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
ERGO |
Based on monthly moving average Entia Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Entia Biosciences by adding Entia Biosciences to a well-diversified portfolio.
Entia Biosciences Valuation on August 7, 2023
It is possible to determine the worth of Entia Biosciences on a given historical date. On August 7, 2023 Entia was worth 2.0E-4 at the beginning of the trading date compared to the closed value of 2.0E-4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Entia Biosciences pink sheet. Still, in general, we apply an absolute valuation method to find Entia Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Entia Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Entia Biosciences' related companies.
Open | High | Low | Close | Volume | |
0.0002 | 0.0002 | 0.0002 | 0.0002 | 1.00 | |
08/07/2023 | 0.0002 | 0.0002 | 0.0002 | 0.0002 | 1.00 |
0.0002 | 0.0002 | 0.0002 | 0.0002 | 1.00 |
Backtest Entia Biosciences | | | Entia Biosciences History | | | Entia Biosciences Valuation | Previous | Next |
Entia Biosciences Trading Date Momentum on August 7, 2023
On August 08 2023 Entia Biosciences was traded for 0.0002 at the closing time. The top price for the day was 0.0002 and the lowest listed price was 0.0002 . There was no trading activity during the period 1.0. Lack of trading volume on August 8, 2023 did not affect price variability. The overall trading delta against the current closing price is 0.00% . |
Entia Biosciences Fundamentals Correlations and Trends
By evaluating Entia Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Entia Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Entia financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Entia Biosciences Pink Sheet history
Entia Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Entia is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Entia Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Entia Biosciences stock prices may prove useful in developing a viable investing in Entia Biosciences
Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products in the United States. Entia Biosciences, Inc. was founded in 2007 and is headquartered in Sherwood, Oregon. Total Nutraceutical operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 6 people.
Entia Biosciences Pink Sheet Technical Analysis
Entia Biosciences technical pink sheet analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, pink sheet market cycles, or different charting patterns.
Price Boundaries
Entia Biosciences Period Price Range
Low | January 10, 2025
| High |
0.00 | 0.00 |
Entia Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on PINK Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Entia Biosciences January 10, 2025 Market Strength
Market strength indicators help investors to evaluate how Entia Biosciences pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Entia Biosciences shares will generate the highest return on investment. By undertsting and applying Entia Biosciences pink sheet market strength indicators, traders can identify Entia Biosciences entry and exit signals to maximize returns
Other Information on Investing in Entia Pink Sheet
Entia Biosciences financial ratios help investors to determine whether Entia Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Entia with respect to the benefits of owning Entia Biosciences security.